In the ordinary course of business, the Company is exposed to foreign currency risk, interest rate risk, equity risk, commodity price changes and credit risk. The Company enters into transactions, and owns monetary assets and liabilities, that are denominated in currencies other than the legal entity’s functional currency. The Company may enter into forward contracts, option contracts, swaps, or other derivative instruments to offset a portion of the risk on expected future cash flows, earnings, net investments in certain foreign subsidiaries and certain existing assets and liabilities. However, the Company may choose not to hedge certain exposures for a variety of reasons including, but not limited to, accounting considerations and the prohibitive economic cost of hedging particular exposures. There can be no assurance the hedges will offset more than a portion of the financial impact resulting from movements in foreign currency exchange or interest rates. Generally, the Company does not use derivative instruments to cover equity risk and credit risk. The Company’s hedging program is not used for trading or speculative purposes.

All derivatives are recognized on the balance sheet at their fair value. Changes in the fair value of derivatives are recorded in the Consolidated Statements of Operations, or as a component of AOCI in the Consolidated Balance Sheets, as discussed below.

To protect gross margins from fluctuations in foreign currency exchange rates, certain of the Company’s subsidiaries with functional currencies that are not in U.S. dollars may hedge a portion of forecasted revenue or costs not denominated in the subsidiaries’ functional currencies. These instruments mature at various dates through November 2021. The Company also uses interest rate derivative contracts to economically convert a portion of its variable-rate debt to fixed-rate debt. The swaps have maturities at various dates through October 31, 2023. Gains and losses on cash flow hedges are recorded in AOCI until the hedged item is recognized in earnings. Deferred gains and losses associated with cash flow hedges of foreign currency revenue are recognized as a component of "Revenue from Services" in the same period as the related revenue is recognized, and deferred gains and losses related to cash flow hedges of costs are recognized as a component of "Cost of revenue" for "services" and/or "Selling, general and administrative expenses" in the same period as the related costs are recognized. Deferred gains and losses associated with cash flow hedges of interest payments are recognized in "Interest expense and Finance charges, net" in the same period as the related expense is recognized. Derivative instruments designated as cash flow hedges must be de-designated as hedges when it is probable the forecasted hedged transaction will not occur in the initially identified time period or within a subsequent two-month time period. Deferred gains and losses in AOCI associated with such derivative instruments are reclassified into earnings in the period of de-designation. Any subsequent changes in fair value of such derivative instruments are recorded in earnings unless they are re-designated as hedges of other transactions.

The Company uses short-term forward contracts to offset the foreign exchange risk of assets and liabilities denominated in currencies other than the functional currency of the respective entities. These contracts, which are not designated as hedging instruments, mature or settle within twelve months. Derivatives that are not designated as hedging instruments are adjusted to fair value through earnings in the financial statement line item to which the derivative relates.

The fair values of the Company’s derivative instruments are disclosed in Note 8-- Fair Value Measurements and summarized in the table below:

	Value as of
Balance Sheet Line Item	November 30, 2019		November 30, 2018
Derivative instruments not designated as hedging instruments:
Foreign exchange forward contracts (notional value)	$	1,192,964	$	1,008,895
Other current assets		11,757		12,651
Other accrued liabilities		2,637		1,856
Interest rate swap (notional value)	$	100,000	$	100,000
Other assets		515		3,519
Derivative instruments designated as cash flow hedges:
Foreign exchange forward contracts (notional value)	$	563,654	$	624,014
Other current assets and other assets		14,523		3,834
Other accrued liabilities and other long-term liabilities		1,633		12,306
Interest rate swaps (notional value)	$	1,900,000	$	1,900,000
Other current assets and other assets		—		5,869
Other accrued liabilities and other long-term liabilities	$	83,428	$	9,004

The notional amounts of foreign exchange forward contracts represent the gross amounts of foreign currency, including, principally, the Philippine Peso, the Indian Rupee, the Euro, the Canadian Dollar, the British Pound, the Chinese Yuan, the Brazilian Real and the Colombian Peso that will be bought or sold at maturity. The term and notional amount of interest rate swaps are determined based on management’s assessment of future interest rates and other factors such as debt maturities. The notional amounts for outstanding derivative instruments provide one measure of the transaction volume outstanding and do not represent the amount of the Company’s exposure to credit or market loss. The Company’s exposure to credit loss and market risk will vary over time as currency and interest rates change.

The Effect of Derivative Instruments on AOCI and the Consolidated Statements of Operations

The following table shows the gains and losses, before taxes, of the Company's derivative instruments designated as cash flow hedges and not designated as hedging instruments in Other Comprehensive Income (“OCI”), and the Consolidated Statements of Operations for the periods presented:

	Location of Gain (Loss)	For the fiscal years ended November 30,
	in Income	2019			2018			2017

Revenue for services		$	4,687,327		$	2,444,867		$	1,974,829
Cost of revenue for services			(2,946,664	)		(1,514,470	)		(1,232,666	)
Selling, general and administrative expenses			(2,084,156	)		(1,376,664	)		(1,041,975	)
Interest expense and finance charges, net			(166,421	)		(84,675	)		(45,357	)
Other income (expense), net			30,363			(8,984	)		1,123

Derivative instruments designated as cash flow hedges:
Gains (losses) recognized in OCI:
Foreign exchange forward contracts		$	20,772		$	27,426		$	—
Interest rate swaps			(88,569	)		(1,256	)		5,957
Total		$	(67,797	)	$	26,170		$	5,957

Gains (losses) reclassified from AOCI into income:
Foreign exchange forward contracts
Gain (loss) reclassified from AOCI into income	Revenue for services	$	127		$	—		$	—
Gain (loss) reclassified from AOCI into income	Cost of revenue for services		16,454			1,021			—
Gain (loss) reclassified from AOCI into income	Selling, general and administrative expenses		6,767			441			—
Gain (loss) reclassified from AOCI into income	Other income (expense), net		36			—			—
Interest rate swaps
Gain (loss) reclassified from AOCI into income	Interest expense and finance charges, net		(8,455	)		2,792			(1,762	)
Total		$	14,929		$	4,254		$	(1,762	)

Derivative instruments not designated as hedging instruments:
Gain (loss) recognized from Foreign exchange forward contracts, net⁽¹⁾	Cost of revenue for services and Selling, general and administrative expenses	$	—		$	3,378		$	—
Gains (losses) recognized from foreign exchange forward contracts, net⁽¹⁾	Other income (expense), net		20,246			(6,126	)		(2,217	)
Gains (losses) recognized from interest rate swaps, net	Interest expense and finance charges, net		(3,004	)		(318	)		—
Total		$	17,242		$	(3,066	)	$	(2,217	)

There were no material gain or loss amounts excluded from the assessment of effectiveness. Existing net losses in AOCI that are expected to be reclassified into earnings in the normal course of business within the next twelve months are $4,126.

In the Consolidated Balance Sheets, the Company does not offset derivative assets against liabilities in master netting arrangements. If derivative exposures covered by a qualifying master netting agreement had been netted in the Consolidated Balance

Sheets, the total derivative asset and liability positions would have been reduced by $6,003 each as of November 30, 2019 and $6,850 each as of November 30, 2018.

Credit exposure for derivative financial instruments is limited to the amounts, if any, by which the counterparties’ obligations under the contracts exceed the Company’s obligations to the counterparties. The Company manages the potential risk of credit losses through careful evaluation of counterparty credit standing and selection of counterparties from a limited group of financial institutions.